Michael J. Higgins

Insider Reports History

Entity
Individual
Location
C/O Genocea Biosciences, Inc., 100 Acorn Park Drive, 5 Th Floor, Cambridge, MA
Signature
By: /s/ Thomas Danielski, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael J. Higgins:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclerion Therapeutics, Inc. Director Common Stock 21.7K $73.5K $3.40 Nov 30, 2023 Direct
Camp4 Therapeutics Corp Director Common Stock 28.7K Oct 10, 2024 Direct
Voyager Therapeutics, Inc. Director Stock Option (Right to Buy) 24K Jun 5, 2024 Direct
GENOCEA BIOSCIENCES, INC. Director Stock Option (Right to Buy) 15K Jul 1, 2021 Direct
Pulmatrix, Inc. Director Stock Option (Right to Buy) 2.44K Jan 26, 2023 Direct

Insider Reports Filed by Michael J. Higgins

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
VYGR Voyager Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
CYCN Cyclerion Therapeutics, Inc. Nov 30, 2023 0 $0 3 Dec 7, 2023 Director
VYGR Voyager Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
PULM Pulmatrix, Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Director
VYGR Voyager Therapeutics, Inc. Jul 14, 2022 1 -$93.1K 4 Jul 18, 2022 Director
VYGR Voyager Therapeutics, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
PULM Pulmatrix, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Director
VYGR Voyager Therapeutics, Inc. Jan 13, 2022 2 $0 4 Jan 18, 2022 Interim President & CEO, Director
GNCA GENOCEA BIOSCIENCES, INC. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
VYGR Voyager Therapeutics, Inc. Jun 3, 2021 1 $0 4 Jun 4, 2021 Interim President & CEO, Director